(Q36146910)

12 August 2017

1 reference

title

Pharmacokinetic variability of anticancer agents (English)

1 reference

12 August 2017

1 reference

3

Mark J Ratain

1 reference

12 August 2017

Samir D Undevia

1

1 reference

PubMed ID

15928675

12 August 2017

Gonzalo Gomez-Abuin

series ordinal

2

1 reference

PubMed ID

15928675

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

12 August 2017

Nature Reviews Cancer

1 reference

12 August 2017

5

1 reference

12 August 2017

447-458

1 reference

12 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1629

12 August 2017

0 references

cites work

Clinical pharmacokinetics-pharmacodynamics of anticancer drugs

1 reference

Pharmacokinetic studies in cancer chemotherapy: usefulness in clinical practice

21 January 2018

1 reference

Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes

21 January 2018

1 reference

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

21 January 2018

1 reference

Oral chemotherapy: rationale and future directions

21 January 2018

1 reference

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

21 January 2018

1 reference

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

21 January 2018

1 reference

Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells

21 January 2018

1 reference

ABC Transporters: From Microorganisms to Man

21 January 2018

1 reference

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

21 January 2018

1 reference

The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery

21 January 2018

1 reference

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

21 January 2018

1 reference

Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.

21 January 2018

1 reference

Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice

21 January 2018

1 reference

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

21 January 2018

1 reference

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

21 January 2018

1 reference

The effect of rifampin treatment on intestinal expression of human MRP transporters

21 January 2018

1 reference

Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

21 January 2018

1 reference

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man

21 January 2018

1 reference

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

21 January 2018

1 reference

The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450

21 January 2018

1 reference

CYP3A gene expression in human gut epithelium

21 January 2018

1 reference

Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues

21 January 2018

1 reference

Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients.

21 January 2018

1 reference

Population pharmacokinetics of raltitrexed in patients with advanced solid tumours

21 January 2018

1 reference

Effects of alpha1-acid glycoprotein on the clinical pharmacokinetics of 7-hydroxystaurosporine

21 January 2018

1 reference

Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy

21 January 2018

1 reference

Pharmacogenomics of the OATP and OAT families

21 January 2018

1 reference

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

21 January 2018

1 reference

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

21 January 2018

1 reference

Substrates of human hepatic cytochrome P450 3A4.

21 January 2018

1 reference

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

A discordance of the cytochrome P450 2C19 genotype and phenotype in patients with advanced cancer

21 January 2018

1 reference

Factors affecting cytochrome P-450 3A activity in cancer patients.

21 January 2018

1 reference

Mechanisms mediating cancer cachexia

21 January 2018

1 reference

Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism

21 January 2018

1 reference

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity

21 January 2018

1 reference

Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity

21 January 2018

1 reference

Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity

21 January 2018

1 reference

Glucuronidation and the UDP-glucuronosyltransferases in health and disease.

21 January 2018

1 reference

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

21 January 2018

1 reference

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

21 January 2018

1 reference

Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8

21 January 2018

1 reference

Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport

21 January 2018

1 reference

Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population

21 January 2018

1 reference

Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells

21 January 2018

1 reference

Determinants of serum antipyrine half-lives in patients with liver disease

21 January 2018

1 reference

Impairment of drug metabolism in patients with liver cancer

21 January 2018

1 reference

Interpatient and intrapatient variability in vinblastine pharmacokinetics

21 January 2018

1 reference

Pharmacokinetic drug interactions of commonly used anticancer drugs.

21 January 2018

1 reference

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 January 2018

1 reference

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

21 January 2018

1 reference

The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR).

21 January 2018

1 reference

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression.

21 January 2018

1 reference

Effects of St. John's wort on irinotecan metabolism

21 January 2018

1 reference

Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice

21 January 2018

1 reference

The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups

21 January 2018

1 reference

Influence of race or ethnicity on pharmacokinetics of drugs

21 January 2018

1 reference

A population pharmacokinetic model for docetaxel (Taxotere): model building and validation

21 January 2018

1 reference

Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel

21 January 2018

1 reference

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

21 January 2018

1 reference

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

21 January 2018

1 reference

Randomized pharmacokinetic and pharmacodynamic study of docetaxel: dosing based on body-surface area compared with individualized dosing based on cytochrome P450 activity estimated using a urinary metabolite of exogenous cortisol

21 January 2018

1 reference

Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic study.

21 January 2018

1 reference

Adaptive control methods for the dose individualisation of anticancer agents

21 January 2018

1 reference

Pharmacokinetic/pharmacodynamic modeling in drug development

21 January 2018

1 reference

Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals

21 January 2018

1 reference

A population model of epirubicin pharmacokinetics and application to dosage guidelines

21 January 2018

1 reference

A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement.

21 January 2018

1 reference

Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines

21 January 2018

1 reference

Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines.

21 January 2018

1 reference

Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer

21 January 2018

1 reference

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

21 January 2018

1 reference

Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancer.

21 January 2018

1 reference

The randomized concentration-controlled trial: An evaluation of its sample size efficiency

21 January 2018

1 reference

Randomized, concentration-controlled trial of topiramate in refractory focal epilepsy

21 January 2018

1 reference

Noncompartmental Determination of the Steady‐State Volume of Distribution

21 January 2018

1 reference

Noncompartmental versus compartmental modelling in clinical pharmacokinetics

21 January 2018

1 reference

21 January 2018

1 reference

Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer

21 January 2018

1 reference

Gastrointestinal absorption as a function of age: xylose absorption in healthy adults.

21 January 2018

1 reference

Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study

21 January 2018

1 reference

21 January 2018

Aging and pharmacology

1 reference

Effects of aging on the renal glomerulus

21 January 2018

1 reference

Chemotherapy in the elderly: pharmacologic considerations

21 January 2018

1 reference

The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells

21 January 2018

1 reference

Cytochromes P-450 in the intestinal mucosa of man

31 March 2020

1 reference

First-pass metabolism of cyclosporin by the gut

31 March 2020

1 reference

No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins

31 March 2020

1 reference

Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR

31 March 2020

1 reference

Potential of chemotherapy?herb interactions in adult cancer patients

31 March 2020

1 reference

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

31 March 2020

1 reference

An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children

31 March 2020

1 reference

Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol

31 March 2020

1 reference

Phase I and pharmacokinetic study of oral paclitaxel

31 March 2020

1 reference

Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer

31 March 2020

1 reference

Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

31 March 2020

1 reference

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group

31 March 2020

1 reference

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

31 March 2020

1 reference

Gazing into a crystal ball-cancer therapy in the post-genomic era

31 March 2020

1 reference

Pharmacology of cancer chemotherapy in the older person.

31 March 2020

1 reference

Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a ra

31 March 2020

1 reference

Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions

31 March 2020

1 reference

Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis

31 March 2020

1 reference

Role of red blood cells in pharmacokinetics of chemotherapeutic agents

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC1629

1 reference

12 August 2017

1 reference

PubMed ID

15928675